Get updates delivered to you daily. Free and customizable.
CNBC
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
By Annika Kim Constantino@annikakimc,
6 days agoBy Annika Kim Constantino@annikakimc,
6 days agoRead in NewsBreak
Comments / 0
Add a Comment
YOU MAY ALSO LIKE
legalexaminer.com8 days ago
A New Ozempic Pill? Roche Shakes Up the Weight Loss Drug Market With Promising Results: See The Data
First For Women20 days ago
chaindrugreview.com2 days ago
CBS News9 days ago
myfourandmore.com16 days ago
rolling out4 days ago
Healthline28 days ago
Healthline28 days ago
CNBC7 hours ago
Colorado State7 days ago
Denver, CO11 days ago
Health12 days ago
Florida State8 days ago
easyhealthoptions.com27 days ago
healio.com20 days ago
LiveScience13 days ago
Get updates delivered to you daily. Free and customizable.
Comments / 0